luspatercept
Showing 1 - 19 of 19
MDS Trial in Beijing (Roxadustat, Luspatercept)
Not yet recruiting
- Myelodysplastic Syndromes
- Roxadustat
- Luspatercept
-
Beijing, ChinaPeking union medical college hospital
Aug 17, 2023
MDS Trial in Houston (Luspatercept)
Not yet recruiting
- Myelodysplastic Syndromes
- Luspatercept
-
Houston, TexasM D Anderson Cancer Center
Nov 2, 2023
Luspatercept in Korean Myelodysplastic Syndrome or ß-thalassemia
Not yet recruiting
- Myelodysplastic Syndrome
- Beta Thalassemia
- Luspatercept
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Oct 3, 2023
Lower Risk MDS Per IPSS-R Trial (Luspatercept)
Not yet recruiting
- Lower Risk MDS Per IPSS-R
- Luspatercept
- (no location specified)
Jun 21, 2023
MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)
Recruiting
- Myelodysplastic Syndromes
- +2 more
- Luspatercept
-
Tampa, FloridaMoffitt Cancer Center
Feb 16, 2023
Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,
Recruiting
- Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
- Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
- Hydroxyurea
- Luspatercept
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 6, 2023
Beta-thalassemia Trial in Nanning (Luspatercept, Placebo)
Recruiting
- Beta-thalassemia
- Luspatercept
- Placebo
-
Nanning, China
- +1 more
Jan 13, 2023
Anemia Trial in Worldwide (biological, drug, other)
Recruiting
- Anemia
- Luspatercept
- +2 more
-
Halifax, Nova Scotia, Canada
- +11 more
Jan 3, 2023
Aplastic Anemia Trial in Beijing (Luspatercept)
Not yet recruiting
- Aplastic Anemia
- Luspatercept
-
Beijing, ChinaPeking union medical college hospital
May 30, 2022
Thalassemia Trial in Worldwide (Luspatercept, Placebo, Best Supportive Care (BSC))
Active, not recruiting
- Thalassemia
- Luspatercept
- +2 more
-
Los Angeles, California
- +16 more
Aug 16, 2022
MDS Trial in Germany (Luspatercept)
Recruiting
- Myelodysplastic Syndromes
- Luspatercept
-
Hamburg, Germany
- +4 more
Dec 20, 2021
MDS Trial in Worldwide (Luspatercept)
Not yet recruiting
- Myelodysplastic Syndromes
- Luspatercept
-
Los Alamitos, California
- +53 more
Sep 13, 2023
Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,
Recruiting
- Autoimmune Hemolytic Anemia
- +5 more
- cytokine essays
- +6 more
-
Milano, ItalyFondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
Jul 3, 2023
Primary Myelofibrosis, Anemia Trial in Worldwide (Luspatercept)
Completed
- Primary Myelofibrosis
- Anemia
- Luspatercept
-
Phoenix, Arizona
- +24 more
Aug 17, 2022
MDS Trial in China, Japan (Luspatercept)
Recruiting
- Myelodysplastic Syndromes
- Luspatercept
-
Beijing, China
- +33 more
Aug 16, 2022
MDS (MDS), Beta-thalassemia, Myeloproliferative Tumor(MPN)-Associated Myelofibrosis Trial in Worldwide (Luspatercept)
Recruiting
- Myelodysplastic Syndromes (MDS)
- +2 more
- Luspatercept
-
Los Angeles, California
- +203 more
Jan 30, 2023
Erythrocyte Transfusion, Beta-Thalassemia Trial in Worldwide (Luspatercept, Placebo)
Completed
- Erythrocyte Transfusion
- Beta-Thalassemia
- Luspatercept
- Placebo
-
Los Angeles, California
- +72 more
Jan 21, 2022
MDS Trial in Worldwide (Luspatercept, Placebo)
Completed
- Myelodysplastic Syndromes
- Luspatercept
- Placebo
-
Stanford, California
- +73 more
Nov 19, 2021